.webp)
DOWNSTREAM ServiceS
07. Market Access & Value Evidence
Secure the commercial transition from "Cleared" to "Adopted" by bridging the gap between clinical performance and economic value. We translate Human Factors data into the language of Payers and Procurement, proving that intuitive design is not a luxury - it is a systematic tool for reducing hospital readmissions, improving adherence, and ensuring long-term reimbursement stability.
OVERCOMING THE ADOPTION THRESHOLD.
“A medical product that is safe but under-reimbursed will never reach the patient. We translate human performance data into value evidence.”
KEY OUTPUTS & DELIVERABLES
Value Dossier Creation
Strategic evidence packages that integrate Usability Data to support pricing and reimbursement strategies.
Budget Impact Modeling
Quantifying how reduced use errors (HFE) directly lower the total cost of care for hospital systems.
Workflow Efficiency Analytics
Data-driven proof of how intuitive design speeds up clinical throughput and reduces staff burden.
07.a
Usability-to-Value Translation
Turning Human Factors data into the economic argument for adoption.
Payers care about outcomes, not specs. We build the Global Value Dossier (GVD) components that prove your device minimizes training time and workflow friction - two of the highest hidden costs in healthcare.
KEY OUTPUTS & DELIVERABLES
Payer In-Depth Interviews (IDIs)
Direct feedback from decision-makers on your value evidence and pricing sensitivity.
Value Proposition Stress-Testing
Qualitative validation of your commercial claims against the operational realities of the payer.
Coding & Pathway Analysis
Verification of existing reimbursement codes and strategic mapping for new clinical pathways.
07.b
Payer & Procurement Research
Identifying the specific evidence required for favorable coverage.
We test your value proposition with the people who hold the budget. By conducting qualitative research with Medical Directors and Procurement officers, we identify the exact evidence needed to justify premium pricing and clear the "Reimbursement Wall".
KEY OUTPUTS & DELIVERABLES
Adherence & Persistence Analysis
Quantifiable proof that superior safety & usability leads to better compliance and clinical outcomes.
Patient-Reported Outcomes (PRO)
Designing tools to capture the patient voice, proving reduced treatment burden and improved quality of life.
Comparative Usability Audits
Post-market benchmarking against incumbents to provide the behavioral evidence needed to drive "Switch Incentives".
07.c
Real-World Evidence (RWE) & Adherence Strategy
Validating the commercial promise beyond the lab.
The real world is messy, and "Instructional Blindness" leads to product abandonment. We design post-market studies to prove that your device performs in the hands of real users, supporting long-term pricing and payer renewals.
The Strategic Outcome
Beyond Clearance: Total Lifecycle Adoption.
The ‘Market Access & Value Evidence’ services ensure your innovation survives the "Valley of Death" between regulatory approval and commercial success. By systematically aligning your HFE evidence with the economic drivers of the healthcare system, we enable a unified commercial vision. We don't just help you get cleared; we help you get prescribed, purchased, and preferred.
Lifecycle Navigator
Exploring Downstream Phase